Par-4 prevents breast cancer recurrence

Nikhil Hebbar; Tripti Shrestha-Bhattarai; Vivek M. Rangnekar

doi:10.1186/bcr3562

Par-4 prevents breast cancer recurrence

Nikhil Hebbar, Tripti Shrestha-Bhattarai, Vivek M. Rangnekar

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

Therapy resistance and disease recurrence are two of the most challenging aspects in breast cancer treatment. A recent article in Cancer Cell makes a significant contribution toward a better understanding of this therapeutic problem by establishing downregulation of the tumor suppressor Par-4 as the primary determinant of breast cancer recurrence. This viewpoint brings forth the importance of their findings and its implications on future research and therapy.

Original language	English
Article number	314
Journal	Breast Cancer Research
Volume	15
Issue number	5
DOIs	https://doi.org/10.1186/bcr3562
State	Published - Oct 25 2013

Bibliographical note

Funding Information:
This work was supported by National Cancer Institute/National Institutes of Health grant CA060872 and Kentucky Lung Cancer Research grant (to VMR).

ASJC Scopus subject areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1186/bcr3562

Cite this

@article{2a2e8cd3edc9435ea8b158bb5cf8d2a0,

title = "Par-4 prevents breast cancer recurrence",

abstract = "Therapy resistance and disease recurrence are two of the most challenging aspects in breast cancer treatment. A recent article in Cancer Cell makes a significant contribution toward a better understanding of this therapeutic problem by establishing downregulation of the tumor suppressor Par-4 as the primary determinant of breast cancer recurrence. This viewpoint brings forth the importance of their findings and its implications on future research and therapy.",

author = "Nikhil Hebbar and Tripti Shrestha-Bhattarai and Rangnekar, {Vivek M.}",

note = "Funding Information: This work was supported by National Cancer Institute/National Institutes of Health grant CA060872 and Kentucky Lung Cancer Research grant (to VMR).",

year = "2013",

month = oct,

day = "25",

doi = "10.1186/bcr3562",

language = "English",

volume = "15",

number = "5",

}

TY - JOUR

T1 - Par-4 prevents breast cancer recurrence

AU - Hebbar, Nikhil

AU - Shrestha-Bhattarai, Tripti

AU - Rangnekar, Vivek M.

N1 - Funding Information: This work was supported by National Cancer Institute/National Institutes of Health grant CA060872 and Kentucky Lung Cancer Research grant (to VMR).

PY - 2013/10/25

Y1 - 2013/10/25

N2 - Therapy resistance and disease recurrence are two of the most challenging aspects in breast cancer treatment. A recent article in Cancer Cell makes a significant contribution toward a better understanding of this therapeutic problem by establishing downregulation of the tumor suppressor Par-4 as the primary determinant of breast cancer recurrence. This viewpoint brings forth the importance of their findings and its implications on future research and therapy.

AB - Therapy resistance and disease recurrence are two of the most challenging aspects in breast cancer treatment. A recent article in Cancer Cell makes a significant contribution toward a better understanding of this therapeutic problem by establishing downregulation of the tumor suppressor Par-4 as the primary determinant of breast cancer recurrence. This viewpoint brings forth the importance of their findings and its implications on future research and therapy.

UR - http://www.scopus.com/inward/record.url?scp=84887511091&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887511091&partnerID=8YFLogxK

U2 - 10.1186/bcr3562

DO - 10.1186/bcr3562

M3 - Article

C2 - 24164776

AN - SCOPUS:84887511091

SN - 1465-5411

VL - 15

JO - Breast Cancer Research

JF - Breast Cancer Research

IS - 5

M1 - 314

ER -

Par-4 prevents breast cancer recurrence

Abstract

Bibliographical note

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this